ESPR

NASDAQ · Equity

Esperion Therapeutics Inc

US Healthcare Drug Manufacturers - Specialty & Generic

Latest week
29 May 2026
Close
3.130000
Fair value
2.123043
Expectation
Positive 59.03%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
3.13
12-Week Change
28.28%
Trend Signal
Inactive
Expectation
Positive 59.03%
Signal Weeks
0 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
-2.73
Market Dynamics
0.17

Over the latest 12 completed weeks ending 2026-05-29, ESPR rose 28.28%, moving from 2.44 to 3.13. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -2.73 and has softened across the 12-week window. Market Dynamics is 0.17 on the latest week. Expectation is positive at 59.03%.